SynthesisFrontiers in neurology2020
Is Guillain-Barré Syndrome Associated With COVID-19 Infection? A Systemic Review of the Evidence.
Synthesis in Frontiers in neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.The Lancet. Neurology · 2024Article
- Impact of infections on the incidence of acute inflammatory demyelinating polyneuropathy in children.Annals of the Child Neurology Society · 2023Article
- Physiotherapy management of a rare variant of Guillain Barre Syndrome, acute motor and sensory axonal neuropathy (AMSAN) along with COVID-19 in a 35-year-old male -a case report.African health sciences · 2022Article
- Article
- Coronavirus infections from 2002 to 2021: neuropsychiatric manifestations.Sleep medicine · 2022Article
- Occupational and Physical Therapy Strategies for the Rehabilitation of COVID-19-Related Guillain-Barré Syndrome in the Long-term Acute Care Hospital Setting: Case Report.JMIR rehabilitation and assistive technologies · 2022Article
- Is there a difference between GBS triggered by COVID-19 and those of other origins?The Egyptian journal of neurology, psychiatry and neurosurgery · 2022Article
- Could Small Neurotoxins-Peptides be Expressed during SARS-CoV-2 Infection?Current genomics · 2021Article
- A 50-Year-Old Patient with Guillain-Barré Syndrome after COVID-19: A Case Report.Medicina (Kaunas, Lithuania) · 2021Article
- Temporal association between SARS-CoV-2 and new-onset myasthenia gravis: is it causal or coincidental?BMJ case reports · 2021Article
- Critical neurological features of COVID-19: Role of imaging methods and biosensors for effective diagnosis.Sensors international · 2021Review
- Detecting Novel Ototoxins and Potentiation of Ototoxicity by Disease Settings.Frontiers in neurology · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.